Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Atopic Dermatitis”

405 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 405 results

Large-scale testing (Phase 3)Study completedNCT05369403
What this trial is testing

Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 86
Testing effectiveness (Phase 2)Study completedNCT04839380
What this trial is testing

The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 49
Not applicableStudy completedNCT06421740
What this trial is testing

An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

Who this might be right for
Atopic Dermatitis
AbbVie 1,000
Early research (Phase 1)Study completedNCT02590289
What this trial is testing

A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects

Who this might be right for
Dermatitis, Atopic
Fresh Tracks Therapeutics, Inc. 20
Post-approval studies (Phase 4)Study completedNCT03868098
What this trial is testing

Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Innovaderm Research Inc. 31
Large-scale testing (Phase 3)Study completedNCT05899816
What this trial is testing

A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)

Who this might be right for
Atopic DermatitisModerate-to-severe Atopic Dermatitis
Amgen 221
Large-scale testing (Phase 3)Study completedNCT06173284
What this trial is testing

Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 519
Large-scale testing (Phase 3)Study completedNCT06238817
What this trial is testing

Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 241
Not applicableEnded earlyNCT05250115
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 112
Early research (Phase 1)Study completedNCT06553287
What this trial is testing

Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Lynk Pharmaceuticals Co., Ltd 28
Not applicableStudy completedNCT03327116
What this trial is testing

Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
University of Sao Paulo General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT04162899
What this trial is testing

A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Reistone Biopharma Company Limited 105
Not applicableStudy completedNCT05394792
What this trial is testing

An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 111
Testing effectiveness (Phase 2)Study completedNCT03915496
What this trial is testing

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 46
Testing effectiveness (Phase 2)Looking for participantsNCT06397911
What this trial is testing

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Oneness Biotech Co., Ltd. 114
Large-scale testing (Phase 3)Looking for participantsNCT06389136
What this trial is testing

Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 200
Early research (Phase 1)Looking for participantsNCT07358156
What this trial is testing

Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

Who this might be right for
Atopic Dermatitis
Chong Kun Dang Pharmaceutical 519
Large-scale testing (Phase 3)Study completedNCT03607422
What this trial is testing

Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)

Who this might be right for
Atopic Dermatitis
AbbVie 912
Early research (Phase 1)Study completedNCT05461456
What this trial is testing

Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%

Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaAtopic Rash+9 more
OrchestratePharma GmbH 12
Testing effectiveness (Phase 2)Study completedNCT02424253
What this trial is testing

Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Ziarco Pharma Ltd 98
Next Page